Blue Sail MedicalLtd Beheer

Beheer criteriumcontroles 3/4

De CEO Blue Sail MedicalLtd is Shuqiao Zhong, benoemd in Jan2022, heeft een ambtstermijn van 2.83 jaar. bezit rechtstreeks 0.044% van de aandelen van het bedrijf, ter waarde CN¥ 2.36M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.6 jaar en 6.2 jaar.

Belangrijke informatie

Shuqiao Zhong

Algemeen directeur

CN¥2.2m

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	2.8yrs
Eigendom CEO	0.04%
Management gemiddelde ambtstermijn	2.6yrs
Gemiddelde ambtstermijn bestuur	6.2yrs

Recente managementupdates

Recent updates

CEO

Shuqiao Zhong (39 yo)

2.8yrs

Tenure

CN¥2,160,000

Compensatie

Mr. Shuqiao Zhong served as Secretary of Blue Sail Medical Co.,Ltd. since October 12, 2018 until July 29, 2022 and has also been its Non-Independent Director since September 13, 2018. He served as General...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Shuqiao Zhong	President	2.8yrs	CN¥2.16m	0.044% CN¥ 2.4m
Yuntao Cui	VP, Accounting Supervisor & CFO	2.6yrs	CN¥1.81m	geen gegevens
Jie Huang	VP, Chief Legal Officer & Board Secretary	2.6yrs	CN¥1.34m	geen gegevens

2.6yrs

Gemiddelde duur

46yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 002382 wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.6 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Shuqiao Zhong	President	6.2yrs	CN¥2.16m	0.044% CN¥ 2.4m
Zhenping Li	Non-Independent Director	14.6yrs	CN¥1.74m	0.55% CN¥ 29.9m
Wenjing Liu	Chairman	11.6yrs	CN¥2.21m	0.37% CN¥ 19.8m
Zhou Zhiwei	Non-Employee Supervisor	10.5yrs	geen gegevens	geen gegevens
Shengjun Liu	Independent Director	6.2yrs	CN¥100.00k	geen gegevens
Shukui Dong	Independent Director	6.2yrs	CN¥100.00k	geen gegevens
Qiuyue Zong	Employee Representative Supervisor	3.9yrs	geen gegevens	0.00095% CN¥ 51.2k
Suhua Yu	Director	2.5yrs	CN¥1.99m	0.019% CN¥ 1.0m
Guitao Qiao	Independent Director	1.5yrs	geen gegevens	geen gegevens
Lingwei Lu	Chairman of the Supervisor Board	1.5yrs	geen gegevens	geen gegevens

6.2yrs

Gemiddelde duur

48.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 002382 wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.2 jaar).

Blue Sail MedicalLtd Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

Blue Sail Medical Co.,Ltd., Annual General Meeting, May 20, 2024

Blue Sail Medical Co.,Ltd., Annual General Meeting, May 20, 2024

Blue Sail Medical Co.,Ltd. Approves Board Appointments

Blue Sail Medical Co.,Ltd., Annual General Meeting, May 22, 2023

High number of new directors

Blue Sail Medical Co.,Ltd., Annual General Meeting, May 05, 2022

Recent updates

Third quarter 2024 earnings released: CN¥0.06 loss per share (vs CN¥0.12 loss in 3Q 2023)

Blue Sail Medical Co.,Ltd. to Report Q3, 2024 Results on Oct 30, 2024

Blue Sail Medical Co.,Ltd.(XSEC:002382) dropped from FTSE All-World Index (USD)

New major risk - Financial data availability

Second quarter 2024 earnings released: CN¥0.06 loss per share (vs CN¥0.15 loss in 2Q 2023)

Blue Sail Medical Co.,Ltd. to Report First Half, 2024 Results on Aug 31, 2024

Blue Sail Medical Co.,Ltd., Annual General Meeting, May 20, 2024

Blue Sail Medical Co.,Ltd., Annual General Meeting, May 20, 2024

First quarter 2024 earnings released: CN¥0.10 loss per share (vs CN¥0.08 loss in 1Q 2023)

Blue Sail Medical Co.,Ltd. to Report Q1, 2024 Results on Apr 27, 2024

Blue Sail Medical Co.,Ltd. (SZSE:002382) commences an Equity Buyback Plan for CNY 50 million worth of its shares, under the authorization approved on March 11, 2024.

Blue Sail Medical Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024

Third quarter 2023 earnings released: CN¥0.12 loss per share (vs CN¥0.033 profit in 3Q 2022)

Blue Sail Medical Co.,Ltd. to Report Q3, 2023 Results on Oct 31, 2023

Second quarter 2023 earnings released: CN¥0.15 loss per share (vs CN¥0.13 loss in 2Q 2022)

Blue Sail Medical Co.,Ltd. Approves Board Appointments

Blue Sail Medical Co.,Ltd., Annual General Meeting, May 22, 2023

First quarter 2023 earnings released: CN¥0.08 loss per share (vs CN¥0.05 loss in 1Q 2022)

Third quarter 2022 earnings released: EPS: CN¥0.033 (vs CN¥0.024 loss in 3Q 2021)

Second quarter 2022 earnings released: CN¥0.13 loss per share (vs CN¥1.69 profit in 2Q 2021)

High number of new directors

First quarter 2022 earnings released: CN¥0.05 loss per share (vs CN¥1.69 profit in 1Q 2021)

Blue Sail Medical Co.,Ltd., Annual General Meeting, May 05, 2022

Blue Sail Medical Co.,Ltd. Proposes Final Cash Dividend for the Year 2021

Full year 2021 earnings released: EPS: CN¥1.13 (vs CN¥1.82 in FY 2020)

Third quarter 2021 earnings released: CN¥0.024 loss per share (vs CN¥1.31 profit in 3Q 2020)

Investor sentiment deteriorated over the past week

Blue Sail Medical Co.,Ltd. Proposes Cash Dividend for the Year 2020

Full year 2020 earnings released: EPS CN¥1.81 (vs CN¥0.51 in FY 2019)

New 90-day low: CN¥20.43

Blue Sail Medical Co.,Ltd. to Report Fiscal Year 2020 Results on Apr 10, 2021

New 90-day high: CN¥26.29

New 90-day low: CN¥20.00

New 90-day low: CN¥22.36

Third quarter earnings released

Blue Sail Medical Co.,Ltd. to Report First Half, 2020 Results on Aug 31, 2020

Blue Sail Medical Co.,Ltd. (SZSE:002382) acquired Wuhan Bikaier Rescue Supplies Co., Ltd. from Zhuhai Blue Sail Juqing Equity Investment Center (Limited Partnership), Sui Jianxun and Fan Furong for approximately CNY 290 million.

Blue Sail Medical Co.,Ltd. (SZSE:002382) completed the acquisition of remaining 6.6% stake in CB Cardio Holdings II Limited from CPBL Limited.

Zhongtai Asset Management cancelled the acquisition of 5.1% stake in Blue Sail Medical Co.,Ltd. (SZSE:002382) from Lanfan Group Co., Ltd

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd